Parliament Approves Import of ADHD Medication Into Maldives

The Parliament has approved the import of medication required for children with Attention-Deficit Hyperactivity Disorder (ADHD) into the Maldives.

The approval was granted following a request submitted by President Dr Mohamed Muizzu seeking parliamentary consent to amend Schedule 1 of the Drugs Act. The matter was reviewed by the Parliament’s Committee on Security Services, also known as the 241 Committee.

advertisement

According to Parliament, the Cabinet had previously discussed recommendations from the National Drug Control Council regarding the import of Methylphenidate, a medication commonly used in the treatment of ADHD.

The Cabinet subsequently decided to seek parliamentary approval to amend the law and remove the medication from the list of substances prohibited for import under the Drugs Act.

Following its review, the Committee on Security Services unanimously approved the proposal to authorise the medication. The committee report was later presented to the parliamentary floor, where members unanimously voted in favour of permitting the import of Methylphenidate into the Maldives.

Methylphenidate is widely used as a first-line treatment for children with ADHD, one of the most common neurodevelopmental conditions identified during childhood.

Studies have shown that ADHD symptoms can be managed through medication and therapeutic interventions.

Relevant authorities have described Methylphenidate as an essential medication required for the treatment of children with ADHD.